Skip to content
Home » LERACE

LERACE

    LERACE

    Lerace (levetiracetam) is used to treat epilepsy.

    Lerace is an antiepileptic drug. It comes as tablets, a liquid, or granules.

    The medicine inhibits burst firing without affecting normal neuronal excitability. It may selectively prevent hyper synchronization of epileptiform burst firing and propagation of seizure activity.

    Lerace should be withdrawn gradually to minimize the potential of increased seizure frequency.

    The medicine is manufactured by Hilton Pharma (Pvt.) Ltd.LERACE

    https://hiltonpharma.com/

    and is available online at:

    https://www.nhs.uk

    Package contains:

    A 60ml bottle containing an oral solution of 100mg/ml approximately.

    Composition:

    Each ml contains:

    Levetiracetam U.S.P  100mg

    Dosage:

    The medicine is indicated as an adjunctive drug of partial-onset seizures in adults and children.

    -Adults and older children (12 years or more):

    250mg to 3000mg a day, taken as 1 or 2 doses

    -Children (aged 1 month to 12 years):

    The dose varies depending on their weight

    How to take:

    You can take lerace with or without food.

    -Tablets: Swallow each tablet with water, milk, or juice. Don’t chew the tablets.

    -Liquid: Swallow whole or mix it in a glass of water, milk, or juice. This comes with a syringe. Don’t use a kitchen spoon as it may not suitable to take the right amount of product.

    -Granules: can be swallowed directly from the packet or mix it with food or water. Drink some water after swallowing them.

    Instructions

    LERACE back

    Store below 30 ⁰ C.

    Protect from heat and sunlight.

    Keep out of the reach of children.

    Warning

    Levetiracetam in Lerace is not safe for some people. Tell immediately your doctor if you:

    • Have ever had any allergy regarding levetiracetam or other medicines in past
    • Are pregnant
    • Have kidney problems

     

    By: Hamna Ghufran

    Leave a Reply

    Your email address will not be published. Required fields are marked *